Annexin A2 combined with TTK accelerates esophageal cancer progression via the Akt/mTOR signaling pathway
2024 · Cell Death and Disease · 23 citations
https://doi.org/10.1038/s41419-024-06683-w
X
Xiaodong Liang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
121
Papers
2.0K
Citations
26
h-index
45
i10-index
Xiaodong Liang is an academic researcher. The author has contributed to research in topics: Esophageal Cancer Research and Treatment & Lung Cancer Diagnosis and Treatment & RNA modifications and cancer. The author has an h-index of 26, co-authored 103 publications.
ORCID: 0000-0001-9479-0936Papers by this author
worksAssociation of pre-surgery to pre-radiotherapy lymphocyte counts ratio with disease-free survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy
2019 · World Journal of Surgical Oncology · 17 citations
https://doi.org/10.1186/s12957-019-1747-9
The clinical efficacy of treatment using the autologous non-cultured epidermal cell suspension technique for stable vitiligo in 41 patients
2019 · Journal of Dermatological Treatment · 16 citations
https://doi.org/10.1080/09546634.2019.1619657
The roles, molecular interactions, and therapeutic value of CDK16 in human cancers
2023 · Biomedicine & Pharmacotherapy · 14 citations
https://doi.org/10.1016/j.biopha.2023.114929
Severe lymphopenia as a prognostic factor in rectal cancer patients receiving adjuvant chemoradiotherapy: a retrospective study
2023 · Scientific Reports · 13 citations
https://doi.org/10.1038/s41598-023-34145-4
Changes in the Psychological State of Medical Personnel in the Department of Radiotherapy at a Tertiary Care Teaching Hospital in China during the Epidemic
2021 · Annals of Work Exposures and Health · 5 citations
https://doi.org/10.1093/annweh/wxab015
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat